Hudson Bay Capital Management LP Denali Therapeutics Inc. Transaction History
Hudson Bay Capital Management LP
- $28.9 Billion
- Q1 2025
A detailed history of Hudson Bay Capital Management LP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 250,000 shares of DNLI stock, worth $3.31 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
250,000
Previous 92,500
170.27%
Holding current value
$3.31 Million
Previous $1.89 Million
80.37%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding DNLI
# of Institutions
234Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$174 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$160 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$156 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$151 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$89.6 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.78B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...